Skip to content Skip to footer

S&P 500 Rallies Despite Fall In Consumer Spending

The S&P 500 rose for a second consecutive day on Friday, despite data showing that consumer spending had fallen in the United States.

Figures released today by the Commerce Department  reported that spending fell by the most in 10 months in February.

The data revealed that spending which accounts for over two-thirds of U.S. GDP fell by 1.0% in February, after rising by 3.4% in January.

Markets had expected a 0.7% decline, mainly due to the energy crisis which took place in parts of the country last month. Many believe spending in March will likely show a greater level of growth.

As of writing the S&P 500 was up 0.84%.

Oil Prices rise on supply concerns

After dropping for the majority of the week, Friday saw a reversal of fortune in oil, as prices climbed by as much as 4%.

Prices climbed as it was reported that concerns of supply were growing, due to the ongoing blockage of a key distribution route.

The block comes around Egypt’s Suez Canal, where it is said that a giant container ship is disrupting the flow of traffic around the Red Sea.

As a result of this, several oil tankers have been forced to divert cargoes, with such diversions sometimes adding as much as 16 days to sailing times.

OPEC+ is also set to meet next week to discuss production cuts, with the cartel likely to take this setback into consideration.

Prices of WTI crude hit an intraday high of $61.26.

Tensions continue between EU, AstraZeneca over  vaccine rollout

The European Union continued its war of words with AstraZeneca on Friday, as it also tightened up rules on vaccine exports.

Many have criticized the EU’s vaccine rollout strategy, which has led to a rebuttal from the union, blaming the slow rollout on missed vaccine delivery targets.

Speaking on the matter, European Commission President Ursula von der Leye stated that, “We want to make sure that Europe gets its fair share of vaccines. Because we must be able to explain to our citizens that if companies export their vaccines to the whole world, it is because they are fully honoring their commitments and it does not risk security of supply in the European Union”.

Whilst alluding to AstraZeneca, the President added that, “We all know, we could have been much faster if all pharmaceutical companies had fulfilled their contracts”.

Quote of the day – “Frankly, I don’t see markets; I see risks, rewards, and money.”

– Larry Hite

Eliman Dambell

Senior Market Analyst
edambell@tvmarkets.com

Tradeview Ltd. is not a portfolio manager or an investment advisor. This Market Report is for informational purposes only. Any statements made or opinions voiced in this Market Report do not constitute investment advice. The Tradeview Ltd. Market Report does not constitute a solicitation to buy or sell in the financial markets. Although the information contained in the Market Report comes from trusted sources, Tradeview Ltd. is not responsible for guaranteeing the accuracy, timeliness, completeness, or fitness of such sources. Tradeview Ltd. shall not be responsible for and disclaims all liability for any losses which may be suffered from access and use of the contents of the Tradeview Ltd. Market Report. Trading any financial instrument on margin, using leverage or otherwise involves considerable risk. Therefore, before deciding to participate in any style of trading, you should carefully consider your investment objectives, level of experience and risk appetite. Most importantly, do not invest money you cannot afford to lose. Consulting with your investment counselor, attorney, accountant or other professional upon whom you rely for guidance as to the appropriateness of an investment in any style of trading is recommended.

Tradeview Ltd.

Is licensed to carry on securities investment business and is regulated by the Cayman Islands Monetary Authority (CIMA) as a full securities broker-dealer. Tradeview conducts business pursuant to the Cayman Islands Securities Investment Business Law (SIBL) and its activities fall under the direct supervision of the Investments and Securities Division of CIMA.
Headquarters: 5th Floor Anderson Square, 64 Shedden Road, Georgetown, Grand Cayman, Cayman Islands KY1-1002, BWI.
Website: www.tradeviewforex.com

Tradeview Asia Ltd.

Is licensed and regulated by the Labuan Financial Services Authority (FSA) as a Money Broker, registration number LL15870 licensed to facilitate transactions in foreign exchange pursuant to Labuan Financial Services and Securities Act 2010, the Labuan Companies Act 1990 and the Labuan Business Activity Tax Act 1990.
Headquarters: International Business Financial Centre at Office 5, Jamie Business Center I, Unit F10, First Floor, Paragon Labuan, Jalan Mustapha, 87000 Labuan F.T.
Website: www.tvmgloballtd.com

Tradeview Europe Ltd.

Is licensed as a Category 2 Investment Service Company and is regulated by the Malta Financial Services Authority (MFSA). The Malta Financial Services Authority (MFSA) is the single regulator for financial services in Malta. MFSA is a fully autonomous public institution and reports to Parliament on an annual basis. The MFSA is a member of the European Banking Authority (EBA), the European Securities and Markets Authority (ESMA) and the International Organization of Securities Commissions (IOSCO) and is a signatory of the Multilateral Memorandum of Understanding with other European regulatory Institutions. Tradeview is authorized to provide financial services across multiple asset classes and is passported in the EU/EEA under MiFID II (EU Markets in Financial Instruments Directive).
Headquarters: 157 Archbishops Street, Valletta VLT Malta 1440.
Website: www.tradeview.eu

Tradeview Financial Markets S.A.C Global

Is authorized to conduct business pursuant to and in compliance with the General Law of Companies (LGS) promulgated by the government of Peru. Tradeview Financial Markets S.A.C is registered with the National Superintendence of Public Registries (SUNARP), company number 13089531. Tradeview Financial Markets S.A.C provides financial services in selected OTC derivative markets in compliance with all applicable government regulations.
Headquarters: Los Mirtos 239 Urb. San Eugenio, Lince, Lima, Perú.
Website: www.tradeviewlatam.com